Newsroom, COVID-19 and Vaccines News Articles and Media

June 2025

May 2025

April 2025

March 2025

February 2025

January 2025

December 2024

November 2024

October 2024

September 2024

August 2024

July 2024

June 2024

press

Ozempic manufacturer gets half the world on the slimming syringe (but not for the same price) (be)

Published by Nieuwsblad

Jun 30, 2024

press

Covid cases brought back from Mecca: the weekly health point (fr)

Published by Agence Ecofin

Jun 29, 2024

press

The new normal: Why do we feel more sick after Covid-19? (es)

Published by El Economista

Jun 28, 2024

press

The EMA gives the green light to the vaccine against the respiratory syncytial virus of the pharmaceutical company Moderna (es)

Published by El Espanol

Jun 28, 2024

press

These diseases have been transmitted more since Covid-19 (fr)

Published by Santé Magazine

Jun 24, 2024

press

Weight loss pills: Everything you need to know

Published by The Telegraph

Jun 24, 2024

press

Because of Corona, we are now sick more often (ch)

Published by Blick

Jun 22, 2024

press

Eli Lilly and Novo Nordisk will invest 30 billion in expanding the production of their therapies against obesity (es)

Published by El Espanol

Jun 22, 2024

press

Data Journalism Top 10: Analyzing Opposition to US Aid for Ukraine, Algorithm to Flag Illegal Timber, Modi’s Lost Support, and Elections in Europe

Published by Global Investigative

Jun 21, 2024

press

Has the pandemic made us sicker?

Published by The Telegraph

Jun 21, 2024

press

How to explain the outbreak of infectious diseases on the planet? (ch)

Published by RTS

Jun 21, 2024

press

Foreign Office warning as tourists get 17th century disease in holiday hotspot

Published by Mirror

Jun 21, 2024

press

Analysis finds global infectious disease outbreaks "surging"

Published by VaccineNation

Jun 19, 2024

press

Why are more people getting sick post-Covid?

Published by Tortoise Media

Jun 18, 2024

press

Analysis reveals global post-covid surge in infectious diseases

Published by The BMJ

Jun 18, 2024

press

Yes, Everyone Really Is Sick a Lot More Often After Covid

Published by Bloomberg

Jun 14, 2024

press

The Big Global Health Mystery Behind Everyone’s Post-Covid Flu

Published by Bloomberg

Jun 14, 2024

press

Vision of trillion-dollar market sparks obesity drugs "gold rush"

Published by The Times

Jun 10, 2024

press

As France braces for 15 million Olympics visitors, its ‘dengue detectives’ are hunting for tiger mosquitoes to prevent an outbreak

Published by Fortune

Jun 5, 2024

Newsroom

In the News

Big Pharma battles for RSV market as Merck and Moderna launch new products (KR)

Trump administration cancels multi-million dollar bird flu vaccine contract with Moderna

Spike in Saudi Mers cases sparks outbreak fears ahead of Hajj

We survived COVID, but getting sick so often now? Here’s what 'immunity debt' means, and why you MUST know it

EU shores up pandemic defences with 478m flu vaccine deal

Tell me more: relationships between fear of missing out, distress and flourishing. A study in 21 countries

GSK and Pfizer reach licensing deal over RSV vaccine

There is no Chinese pharmaceutical and bio in Trump variables (ko)

The future of weight loss drugs: gummies, tablets and melt-in-the-mouth strips

Global pharmaceutical companies' new drug-based Chinese... technology export, FDA approval one after another (ko)

A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein

Will an asteroid wipe out humanity? AI could destroy us first

Pharma industry supports the Ifpma's plan to activate a global action before the NTS (es)

Five years of corona pandemic: How British researchers developed vaccine (de)

Roche Bets $5.3 Billion on Obesity Market’s Shifting Goalposts

Value of investment on NCDs: Impact on health outcomes in low- and middle-income countries

Big Pharma Issues Global ‘Call to Action’ to Address NCD Crisis

Five years after the outbreak of the Covid-19 pandemic: How long does vaccine immunity last? (es)

Pfizer wins the battle against GSK in the vaccine market against the respiratory syncytial virus in 2024 (es)

India sees record surge in stomach bug outbreaks

Record Stomach Flu Outbreaks in India Show Lurking Health Risks

Cutting edge Oxford malaria vaccine trial in jeopardy as USAID payments frozen

Rapid trials prompt deals rush for Chinese ‘super me-too’ drugs

The new wave of drugs against obesity (es)

Inhalon Biopharma Announces First-of-its-Kind Inhaled Antibody Treatment for RSV to Enter Human Clinical Trials

India Is Powering the Fight Against a Silent ‘Superbug’ Pandemic

Bill Gates predicts what could be a new epidemic (pt)

Bill Gates has warned of the probability of a new epidemic: the millionnaire assures that we are not prepared to face it

Britons face paying more for weight-loss jabs... to make them cheaper for Americans

The rising threat of deadly diseases jumping from animals to humans

GSK, Pfizer RSV Shots Required to Carry Guillain-Barré Syndrome Warnings

RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate

Dengue, mpox, bird flu... 2025 comes with threat of resurgence of infectious diseases

Global Disease Resurgence in 2024 Shows Rising Health Threat

Resurgence of Diseases Threatens Global Public Health

Dengue, mpox, bird flu... 2025 comes with threat of resurgence of infectious diseases

The Coming Wave of New Obesity-Treatment Drugs

What other conditions could weight-loss drugs treat?

Europe tightens H5N1 surveillance as winter flu season looms

UK Patent Win Over GSK Boosts Pfizer in Global RSV Vaccine Fight

Paxlovid scandal: Sonneborn calculates 417 years in prison for Karl Lauterbach

Vaccine stocks sag in US, Europe after RFK Jr.'s HHS appointment

Novo’s New Obesity Drug Is Targeting the Most Dramatic Weight Loss Yet

CDC Reaffirm RSV Vaccination Guidelines, Declines Expanding Coverage to Younger Adults

GLP-1s like Ozempic are among the most important drug breakthroughs ever

Merck, Pfizer Tout Promising Respective Data in RSV With High Rates of Prevention

Mounjaro v Ozempic: Inside the race to reveal the best weight-loss jab

The pandemic's 'far-reaching' impact on dentistry

VIRAL THREAT Risk of bird flu combining with seasonal flu to create mutant strain is 5 times higher – raising ‘pandemic’ fears

H5N1 could combine with seasonal flu to create a more dangerous virus strain

New INTREPID Alliance Antiviral Landscape Report Highlights Urgent Need to Bolster R&D Pipeline in Support of Global Pandemic Preparedness Efforts

GSK touts 3-year data on RSV shot Arexvy after CDC's narrower usage recommendation

GSK ex-vaccines chief says group’s blockbuster flu jab is too expensive

Novo’s Wegovy Puts a Higher Price on Heart Health in the US

Novo’s Wegovy Price Tag for Stroke Prevention Is Higher in US

GSK pursues co-administration of RSV and shingles vaccines

GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales

Will Mpox be the new Covid?

Uncertainty about billion-dollar potential behind Bavarian's latest cup rate

First Ozempic-style weight-loss pill could be available within two years

Cost-benefit of Influenza Vaccinations in Frontline Workers: A Dynamic Modelling Study

The IFPMA lists the main challenges to promote the development of new antibiotics (es)

Countries should act faster to curb the spread of mpox

BioNTech/Pfizer Covid and flu combo vaccine falters in late-stage trial

Weight loss pill - new boom for Novo Nordisk, Eli Lilly and Co.? (de)

RSV vaccine makers remain optimistic about market despite CDC guidance

GSK strengthens its position as the RSV vaccine leader: It earns 112 million more than Pfizer in the first half of the year (es)

GSK cuts vaccine sales outlook after RSV surprise, but CEO puts on bold front on peak potential

Moderna: State of play ahead of Q2 earnings, I'm (temporarily) pesimistic

With new CDC recommendations, RSV market's long-term value falls sharply in US: Airfinity

RSV vaccine market to decline 64% on CDC decision: report

The competitors with whom Novo and Lilly will compete for the obesity market (es)

Airfinity US RSV vaccine market estimate cut by 64% from $4.7bn to $1.7bn a year by 2030 following recommendations for single lifetime shot for elderly people

GSK, Pfizer and Moderna face RSV vaccine sales slump

How France is preparing for dengue ahead of 'super-spreader' Paris Olympics

How a single daily pill could soon be the future of losing weight

Are we sicker after the pandemic? Experts analyze outbreaks of infections

Anti-obesity medicines will move up to 150 billion by 2030 (es)